Patents
Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008)
08/2006
08/22/2006US7094769 2-aminocarbonyl-9H-purine derivatives
08/22/2006US7094768 Nucleoside derivatives for treating hepatitis C virus infection
08/17/2006WO2006001982A3 Methods and compositions for treating neuropathies
08/17/2006US20060183707 Production method of 2'-deoxyguanosine compound
08/17/2006US20060183706 2-Beta-modified-6-substituted adenosine analogs and their use as antiviral agents
08/17/2006US20060183204 Reacting a nucleoside triphosphate with a periodate and amine compound and sodium borohydride, attaching label, a protein, an enzyme, a fatty acid, and a peptide, producing nucleic acid (DNA or RNA) fragments enzymatically extended with morpholino-nucleoside triphosphates; dna polymerases
08/16/2006EP1689347A2 Methods and reagents for treating, preventing and diagnosing bunyavirus infection
08/16/2006EP0527917B2 Use of adenosine and adenosine derivatives for anesthesia
08/16/2006CN1818076A Nucleic acid labeling methods
08/16/2006CN1818074A Method of preparing a guanosine-group compound and an intermediate thereof
08/16/2006CN1818073A Method of preparing a guanosine-group compound and an intermediate thereof
08/16/2006CN1817349A Nucleoside analogues with carboxamidine-modified monocyclic base
08/15/2006US7091190 Synergistic inhibition of viral replication by long-chain hydrocarbons and nucleoside analogs
08/15/2006US7090975 Pyrophosphorolysis and incorporation of nucleotide method for nucleic acid detection
08/15/2006CA2211612C [5-carboxamido or 5-fluoro]-[2',3'-unsaturated or 3'-modified]-pyrimidine nucleosides
08/15/2006CA2190983C New lipid esters of nucleoside monophosphates and their use as immunosuppressive drugs
08/10/2006WO2006084067A2 Dark quenchers, probes and other conjugates incorporating the same, their use
08/10/2006WO2006081665A1 Purine nucleoside analogs
08/10/2006WO2006044918A3 Compounds useful as substrates for enzymes that reverse nucleotidylylated peptide and protein modifications and methods for production and uses thereof
08/10/2006US20060178319 antibiotics; caprazamycin B is subjected to acid-hydrolysis
08/10/2006US20060177857 Dark quenchers, probes and other conjugates incorporating the same, and their use
08/10/2006CA2596142A1 Adenosine analogs useful as anti-bacterial and anti-protozoan agents
08/09/2006EP1687324A2 Improved expression systems with sec-system secretion
08/09/2006EP1687321A1 Nucleoside compounds for treating viral infections
08/09/2006EP1565481B1 Antiviral nucleoside derivatives
08/09/2006EP1423400B1 Evolving new molecular function
08/09/2006CN1816558A Modified fluorinated nucleoside analogues
08/09/2006CN1814614A Nucleic acid, peptide nucleicacid derivatives and their use
08/09/2006CN1814606A Method for modifying nucleoside by medicinal molecules with carboxy or hydroxy
08/09/2006CN1268633C Preparation and isolation of indolocarbazole glycosides
08/09/2006CN1268345C Method of treating hepatitis delta viral infection
08/09/2006CN1268335C Nucleoside analogs with carboxamidine wodified monocyclic base
08/08/2006US7087744 Comprises azamethine/nucleic acid complex; reverse transcription; transferases
08/08/2006US7087732 Nucleotides and analogs having photoremovable protecting groups
08/08/2006US7087428 Secreted and transmembrane polypeptides and nucleic acids encoding the same
08/08/2006US7087384 Rare earth metal cryptates which are not very sensitive to the fluorescence quenching
08/03/2006WO2006080509A1 Novel pyrimidine nucleoside compound or its salt
08/03/2006WO2006080421A1 Spiroketal derivative and use thereof as diabetic medicine
08/03/2006WO2006032893A3 Trityl derivatives for enhancing mass spectrometry
08/03/2006US20060173174 Difluoronucleosides and process for preparation thereof
08/03/2006US20060173173 2' -0-Trisubstituted silyloxymethyl-ribonucleoside-derivative and method for preparing the same
08/03/2006US20060172327 Sequencing of surface immobilized polymers utilizing microflourescence detection
08/03/2006US20060172309 5-methylcytosine detection, compositions and methods therefor
08/03/2006CA2596235A1 Spiroketal derivatives and use thereof as diabetic medicine
08/03/2006CA2596060A1 Novel pyrimidine nucleoside compound or salt thereof
08/02/2006CN1812995A Industrially scalable nucleoside synthesis
08/02/2006CN1810822A 2-aminocarbonyl-9h-purine derivatives
08/02/2006CN1267446C Nucleoside derivatives as inhibitors of RNA-dependent PNA viral polymerase
08/02/2006CN1267445C Inner salt type compound of thiophosphate group containing fluorin added and synthesis
08/02/2006CN1267444C Compound thiophosphates containing selenium with fluorin being added to and synthesis
08/01/2006US7084128 Administering purinerginic receptor ligand, which is a mononucleoside polyphosphate or dinucleoside polyphosphate such as di-5'-((2'O-benzyl)adenosine)tetraphosphate; for treatment of glaucoma
08/01/2006US7084127 C2,5′-disubstituted and N6, C2,5′-trisubstituted adenosine derivatives and their different uses
08/01/2006US7084125 Xylo-LNA analogues
08/01/2006US7083987 Using fluorescent compound to analysis protein complexes; determination of genome sequence
08/01/2006CA2192073C Novel oligosaccharide derivatives, preparation method therefor and uses thereof
07/2006
07/27/2006WO2006077816A1 Imidazopyridine derivative
07/27/2006WO2006012440A3 Preparation of alkyl-substituted 2-deoxy-2-fluoro-d-ribofuranosyl pyrimidines and purines and their derivatives
07/27/2006WO2005060675A3 Novel spliced 5-ht1a receptors and methods, kits, and uses relating thereto
07/27/2006US20060167241 Method for synthesizing cyclic bisdinucleoside
07/27/2006US20060166926 small molecules that modulate premature translation termination and/or nonsense-mediated mRNA decay; treating cystic fibrosis or muscular dystrophy
07/27/2006US20060166925 Substitution derivatives of n6-benzyladenosine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds
07/27/2006US20060166908 Nucloeside analogues and oligonucleotide derivative comprising nucleotide analogue thereof
07/27/2006US20060166865 A modified nucleoside comprising a purine ring for treating viral infections
07/27/2006US20060166331 Pharmaceutical grade manufacture of quality plasmid DNA from cell lysates using flotation to separate and eliminate undesired insoluble cellular debris including chromosomal DNA from the lysates
07/27/2006US20060166248 Fluorescent N2, N3-etheno-purine (2'deoxy) riboside derivatives and uses thereof
07/26/2006EP1683871A2 Nucleic acid ligands and methods for producing the same
07/26/2006EP1683806A1 Production method of 2'-deoxyguanosine compound
07/26/2006EP1682564A1 METHODS FOR PREPARING 7-(2 -SUBSTITUTED-s-D-RIBOFURANO SYL)-4-(NR2R3)-5-(SUBSTITUTED ETHYN-1-YL)-PYRROLO 2,3-D|PYRIMIDINE DERIVATIVES
07/26/2006CN1809582A Processes for preparing 4acoeazido nucleoside derivatives
07/26/2006CN1266161C Synthesis process of adenosine aose monophosphate
07/25/2006US7081526 May be used for the analysis of nucleic acid sequences by incorporating these derivatives into nucleic acid chains, and also the enzymatic labelling and immobilization or detection of sequences
07/25/2006US7081524 O2-substituted 1-[(2-carboxylato)pyrrolidin-1-yl]diazen-1-ium-1,2-diolates
07/25/2006US7081449 Induce apoptosis; anticancer agents
07/20/2006WO2006075993A2 Nucleoside derivatives for treating hepatitis c virus infection
07/20/2006WO2005111070A3 Mucin3 egf-like domains
07/20/2006US20060160798 3-Cyclohexyl-1-methyl-2-pyridin-2-yl-1H-indole-6-carboxylic acid methyl ester; hepatitis C virus infection; synergistic with another inhibitor of HCV polymerase or immunomodulatory agent such as interferons
07/20/2006US20060160765 Inhibitors of nucleoside phosphorylases and nucleosidases
07/20/2006US20060160081 Labelled nucleotides
07/20/2006US20060160075 nucleotides having a removable labels, used in polynucleotide sequencing
07/20/2006CA2562224A1 Nucleoside derivatives for treating hepatitis c virus infection
07/19/2006EP1680436A1 Nucleoside compounds for treating viral infections
07/19/2006EP1680435A1 Acyl ribonucleosides and acyl deoxyribonucleosides
07/19/2006CN1806050A Methods for rapid purification of nucleic acids for subsequent analysis by mass spectrometry by solution capture
07/19/2006CN1805962A Inosine derivatives and production methods therefor
07/19/2006CN1803822A Method for preparing adenosine
07/18/2006US7078518 Forms of 5-Azacytidine
07/18/2006US7078499 Where reporter moiety does not also act as a polymerase enzyme blocking moiety
07/18/2006US7078391 Method of treating edematous retinal disorders
07/18/2006US7078195 Useful as anti-bacterial agents
07/18/2006CA2384838C Methods and compositions for linear isothermal amplification of polynucleotide sequences
07/13/2006WO2006074416A1 5-amino-4-imidazolecarboxamide riboside and its nucleobase as potentiators of antifolate transport and metabolism
07/13/2006WO2006037028A3 Methods and compositions for treating flaviviruses, pestiviruses and hepacivirus
07/13/2006WO2006033730A3 Novel polynucleotide synthesis labeling chemistry
07/13/2006WO2005117910A3 Purine derivatives as adenosine a1 receptor agonists and methods of use thereof
07/13/2006US20060155123 Donor dye with absorption maxima at 250-450 nm wavelength; acceptor dye emitting light with maxima greater than 500 nm. in response to absorbing energy emitted by doner; especially with donor and acceptor dyes linked together
07/13/2006US20060154889 Polyfluorinated nucleoside analogs and methods of use thereof
07/13/2006US20060154253 Method for the validated construction of arrays
07/12/2006EP1678192A1 Process for the preparation of doxifluridine
07/12/2006EP1677822A2 4'-thionucleosides and oligomeric compounds
07/12/2006EP1677805A2 Pancreatic cancer treatment
1 ... 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 ... 201